Myriad RBM joins Institut Pasteur in the global fight against tuberculosis

SALT LAKE CITY, Jan. 20, 2015 -- Myriad RBM, a wholly owned subsidiary of Myriad Genetics, Inc. (Nasdaq:MYGN), today announced that it will assist the Institut Pasteur in a public-private research collaboration to fight the global tuberculosis (TB) epidemic. This research project is funded by the Bill & Melinda Gates Foundation through a grant to the Institut Pasteur.